Academic Appointments

2013-2016      Adjunct Professor, University of Utah, Department of Neurological Sciences

2016-2020      Assistant Professor, University of Vermont, Department of Neurological Sciences

2020-2023      Associate Professor, University of Vermont, Department of Neurological Sciences

2024-Present  Professor, University of Vermont, Department of Neurological Sciences

Board Certification

2016-Present  Vermont Medical Licensure
2015-Present  American Association of Neuromuscular & Electrodiagnostic Medicine
2012-Present  American Board of Psychiatry & Neurology
2012-Present  Utah Medical Licensure
2008-Present  Advanced Cardiac Life Support

Education

2014-2016  University of Utah, Salt Lake City, Utah, Vice President's Clinical and Translational Science Scholarship

2014-2016  University of Utah, Salt Lake City, Utah, Masters in Clinical Investigation

2014-2016  University of Utah, Salt Lake City, Utah, KL2 Scholar

2012-2013  University of Utah, Salt Lake City, Utah, Fellow Physician Department of Neurology,      Electriohysiology (EMG) Fellowship

2011-2012  University of Virginia Health System, Charlottesville, Virginia, Chief Resident, Department of Neurology

2008-2012  University of Virginia Health System, Charlottesville, Virginia, Resident Physician, Department of Neurology

2004-2008  University of Massachusetts Medical School, Worcester, Massachusetts, Doctor of Medicine

1999-2003  Bowdoin College, Brunswick, Maine, Bachelor of Arts, Biochemistry

Awards and Honors

2008  Graduated Alpha Omega Alpha (AOA)

2008  American Academy of Neurology (AAN) Excellence in Neurology Award for a Medical Student

2010  Mullholland Resident and Fellow Teaching Award

2011  UVA School of Medicine's Humanism and Excellence in Teaching Award

2011 UVA Emergency Room Consultant of the Year

2012  UVA All University School of Medicine Resident Teaching Award

Research

Development of a Risk Prediction Model for Chemotherapy Induced Peripheral Neuropathy. Lake Champlain Cancer Research Organization. Using the vast cancer data housed in the Utah Cancer Registry, this project uses both conventional statistical modeling as well as advanced computing technology called genetic programming to build a new model to predict the risk of developing chemotherapy induced neuropathy.
Role: PI

TopCSPN is a double blinded randomized placebo controlled trial of oral topirimate as a potential disease altering therapy for cryptogenic sensory peripheral neuropathy.
Role: Medical safety supervisor